EGFRI Induced Acneiform Lesions

Clinical trial pipeline · Data from ClinicalTrials.gov

See which EGFRI Induced Acneiform Lesions trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT04759664

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

The study evaluates the efficacy and safety of two strengths of LUT014 Gel topically applied once a day for 4 weeks, compared to placebo, in metastatic colorect…

United States117 participantsStarted 2021-04-12

Treatment: LUT014 Gel (Dose 1), LUT014 Gel (Dose 2)